AOD-9604 isolates the fat cell targeting properties of growth hormone without affecting the GH/IGF-1 axis
In a transected rat sciatic nerve model (Gjurasin et al., 2010, published in Regulatory Peptides), BPC-157 promoted functional nerve reconnection and accelerated axonal sprouting, with treated animals recovering motor function significantly faster than controls
Personalized Protocols Our team helps determine the appropriate drip or vitamin shot based on your goals
BPC-157 enhances digestive function, allowing smoother intestinal contractions, improved nutrient absorption, and more efficient digestion overall
magna organisms, but because the lower sample biomass (5-day-old D
The GLOW Protocol typically features a compounded peptide formulation containing: GHK-Cu 10 mg BPC-157 3 mg TB-500 3.75 mg per mL This protocol is typically used as part of a 30-day regimen , though treatment recommendations may vary depending on the patient, goals, and provider guidance
